REG - CVS Group plc - Long Term Incentive Plan Awards & PDMR Dealing

CVSAnnouncement

07/10/2021 07:05

RNS Number : 2761O
  
CVS Group plc
  
07 October 2021
  
 

6 October 2021
CVS Group Plc
("CVS", the "Company" or the "Group")
Long Term Incentive Plan Awards & PDMR Dealing
CVS, one of the UK's leading providers of integrated veterinary services, announces that it has granted option awards over a total of 74,174 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2021 ("LTIP 15") (the "Options").  As detailed below, certain of the Options were awarded to the Directors named below, with the balance being issued to certain other employees.
Options awarded to Directors
Name                                    Role                                                       Number of Options
Richard Fairman                Chief Executive Officer                                  21,188  
Ben Jacklin                          Chief Operating Officer                                 12,712
Robin Alfonso                    Chief Financial Officer                                    11,009


The awards will vest in three years' time, subject to certain performance criteria being satisfied.  These vesting criteria relate to the Company's earnings per share growth and total shareholder return over the three-year period between 1 July 2021 and 30 June 2024.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.





Contacts:


















CVS Group plc


via MHP Communications




Richard Fairman, CEO








Jenny Farrer, Company Secretary


















Singer Capital Markets (Nominated Adviser & Broker)                 


+44 20 7496 3000




Aubrey Powell / Jen Boorer / Rachel Hayes


 














MHP Communications (Financial PR)


+44 20 3128 8549




Andrew Jaques / Rachel Mann / Charles Hirst







 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 
 


Richard Fairman
 




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Chief Executive Officer




b) 
 


Initial notification /Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CVS Group plc




b) 
 


LEI 
 
 


213800J41XDQ2NX48O05




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 
 


Options over ordinary shares of 0.2 pence each
 
 
GB00B2863827
 




b) 
 


Nature of the transaction 
 
 


Grant of options under LTIP 15




c) 
 


Price(s) and volume(s) 
 
 


 



Price(s)
 


Volume(s)




Exercise price of 0.2p


21,188



 
 




d) 
 


Aggregated information 
 
- Aggregated volume 
 
 
- Price 
 


N/A
 
 
 




e) 
 


Date of the transaction 
 
 


6 October 2021




f) 
 


Place of the transaction 
 
 


Off market



 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 
 


Ben Jacklin




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Chief Operating Officer




b) 
 


Initial notification /Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CVS Group plc




b) 
 


LEI 
 
 


213800J41XDQ2NX48O05




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 
 


Options over ordinary shares of 0.2 pence each
 
 
GB00B2863827
 




b) 
 


Nature of the transaction 
 
 


Grant of options under LTIP 15




c) 
 


Price(s) and volume(s) 
 
 


 



Price(s)
 


Volume(s)




Exercise price of 0.2p


12,712



 
 




d) 
 


Aggregated information 
 
- Aggregated volume 
 
 
- Price 
 


N/A
 
 
 




e) 
 


Date of the transaction 
 
 


6 October 2021




f) 
 


Place of the transaction 
 
 


Off market



 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 
 


Robin Alfonso




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Chief Financial Officer




b) 
 


Initial notification /Amendment 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 


 




a) 
 


Name 
 
 


CVS Group plc


 




b) 
 


LEI 
 
 


213800J41XDQ2NX48O05


 




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 


 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 
 


Options over ordinary shares of 0.2 pence each
 
 
GB00B2863827
 


 




b) 
 


Nature of the transaction 
 
 


Grant of options under LTIP 15


 




c) 
 


Price(s) and volume(s) 
 
 


 



Price(s)
 


Volume(s)




Exercise price of 0.2p


11,009



 
 


 




d) 
 


Aggregated information 
 
- Aggregated volume 
 
 
- Price 
 


N/A
 
 
 


 




e) 
 


Date of the transaction 
 


6 October 2021


 




f) 
 


Place of the transaction 


Off market


 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCEAPEKEFAFFFA